Skip to main content
Clinical Trials/JPRN-UMIN000008332
JPRN-UMIN000008332Completed未知

Evaluation of effect of Glubes combination tablet on the HbA1c levels and vascular endothelial function - EGEF trial

The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University0 sites16 target enrollmentStarted: July 3, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
16

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients fulfilling any of the following criteria will be excluded. 1)Having some contraindication to use of mitiglinide or voglibose 2)Excessive alcohol intake 3)Severely impaired liver or kidney function 4)Age <=75 years 5)Duration of diabetes >=10 years 6)Use of the study drug, glinide, or AGI within the previous 8 weeks 7)Ongoing treatment with a DPP-4 inhibitor, GLP-1 analog, or insulin 8)Any other condition that may potentially affect the efficacy evaluation

Investigators

Sponsor
The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University

Similar Trials